investor losses

Upstart Holdings faces class action lawsuit alleging misleading statements about AI Model 22's performance. Stock fell 9.71% after November disclosure of model calibration issues.

Lufax faces securities class action lawsuit alleging disclosure violations and fraud. Investors with losses can seek lead plaintiff status by May 20, 2026.

Stellantis faces securities fraud class action after stock plummeted 23.69% following disclosure of €22 billion in charges and business reset amid misrepresented electrification strategy.

Law Offices of Howard G. Smith seeks lead plaintiffs in securities fraud cases against $CHOW, $GO, $ALIT, $IT before mid-May 2026 deadline.

Securities fraud lawsuit targets $CHOW over alleged pump-and-dump manipulation scheme that triggered devastating 84% stock collapse in December 2025.

Law Offices of Howard G. Smith initiates securities fraud class actions against $PINS, $NUAI, $GOSS, and $MEDP; investors have until May-June 2026 deadline for lead plaintiff motions.

Corcept Therapeutics faces class action lawsuit alleging investor deception over failed relacorilant drug trial. Stock plunged 50.4% after FDA rejection.

Rosen Law Firm urges Snowflake investors with $100K+ losses to act before April 27, 2026 deadline in securities class action alleging undisclosed product efficiency and pricing impacts.

Rosen Law Firm urges $FBRT investors with $100K+ losses to seek counsel before April 27, 2026 lead plaintiff deadline in securities class action over allegedly false dividend sustainability claims.

Immutep's $IMMP shares plummeted after discontinuing Phase III trial for cancer drug. Rosen Law Firm investigates potential securities fraud claims.

Disc Medicine ($IRON) shares fell 22% after FDA rejected its bitopertin drug application, prompting class action investigation into securities claims.

Lakeland Industries investors with $100K+ losses must join securities lawsuit by April 24, 2026, alleging false statements about Pacific Helmets and Jolly businesses.

Rosen Law Firm filed securities class action against Navan, Inc. and others for allegedly misleading offering documents. Investors with $100K+ losses must act before April 24, 2026 deadline.

Navan faces class action lawsuit alleging IPO prospectus omitted material facts about 39% jump in sales and marketing expenses. Stock has crashed 63% since October IPO.

Rosen Law Firm initiates class action against $ENPH for alleged misstatements on inventory management and tax credit impacts. April 20, 2026 lead plaintiff deadline.

ADMA Biologics ($ADMA) stock crashed 16.6% following channel stuffing allegations. Rosen Law Firm launches investigation into securities fraud claims.

Rosen Law Firm investigates Barclays $BCS over £600M exposure to collapsed UK mortgage lender, triggering 6%+ stock decline.

Rosen Law Firm urges $PYPL investors with $100K+ losses to join securities class action by April 20 deadline over alleged misleading statements about checkout business performance.

Class action lawsuit filed against $EOSE for alleged false statements on production capacity and quality control issues. Lead plaintiff deadline: May 5, 2026.

Upstart Holdings faces class action lawsuit alleging false claims about its AI Model 22 risk assessment tool. Investors can join until June 8, 2026.